Joel W. Proksch
Reata Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Antibiotics Pharmacokinetics and Efficacy, Ocular Infections and Treatments, Intraocular Surgery and Lenses, Genomics, phytochemicals, and oxidative stress, Receptor Mechanisms and Signaling
Most-Cited Works
- → Azepanone-Based Inhibitors of Human and Rat Cathepsin K(2001)102 cited
- → Topical Application of the Synthetic Triterpenoid RTA 408 Protects Mice from Radiation-Induced Dermatitis(2014)77 cited
- → Ocular Pharmacokinetics of Besifloxacin Following Topical Administration to Rabbits, Monkeys, and Humans(2009)67 cited
- → <p>Pharmacokinetics and pharmacodynamics of the novel Nrf2 activator omaveloxolone in primates</p>(2019)62 cited
- → Topical application of the synthetic triterpenoid RTA 408 activates Nrf2 and induces cytoprotective genes in rat skin(2013)61 cited
- → Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors(2017)54 cited
- → A Single Dose of Monoclonal Anti-Phencyclidine IgG Offers Long-Term Reductions in Phencyclidine Behavioral Effects in Rats(2002)47 cited
- → Bardoxolone methyl analog attenuates proteinuria‐induced tubular damage by modulating mitochondrial function(2019)46 cited
- → A rapid and sensitive LC/MS/MS assay for the quantitation of brimonidine in ocular fluids and tissues(2008)45 cited
- → DEVELOPMENT OF AN IN VIVO PRECLINICAL SCREEN MODEL TO ESTIMATE ABSORPTION AND FIRST-PASS HEPATIC EXTRACTION OF XENOBIOTICS. II. USE OF KETOCONAZOLE TO IDENTIFY P-GLYCOPROTEIN/CYP3A-LIMITED BIOAVAILABILITY IN THE MONKEY(2004)43 cited